CBGA, or cannabigerolic acid, is the chemical precursor that cannabis plants use to produce THC, CBD, and most other cannabinoids. It’s often called the “mother of all cannabinoids” because without it, the compounds people associate with weed simply wouldn’t exist. CBGA itself doesn’t get you high, but it plays a foundational role in determining what a cannabis plant ultimately produces.
How CBGA Becomes Every Major Cannabinoid
Cannabis plants build CBGA by combining two smaller molecules: olivetolic acid and geranyl pyrophosphate. This reaction happens inside the plant’s cells, primarily in the tiny resin glands (trichomes) that coat the flowers and leaves. Once CBGA is formed, it sits at a biochemical crossroads.
From there, three different enzymes compete for CBGA and convert it into one of three acidic cannabinoids:
- THCA synthase converts CBGA into THCA, the precursor to THC
- CBDA synthase converts CBGA into CBDA, the precursor to CBD
- CBCA synthase converts CBGA into CBCA, the precursor to CBC
Which enzyme dominates depends on the plant’s genetics. A high-THC strain has more THCA synthase activity, so most of its CBGA gets funneled toward THCA. A high-CBD hemp variety directs CBGA primarily toward CBDA instead. This is why a single plant rarely produces equally high levels of both THC and CBD. The enzymes are essentially competing for the same limited pool of CBGA.
Why Most Cannabis Has Very Little CBGA
Because CBGA is a starting material that gets converted into other cannabinoids, mature cannabis flowers typically contain very little of it. The plant produces CBGA throughout its life, but the enzymes keep converting it almost as fast as it’s made. By the time a plant reaches full maturity and harvest, most of the CBGA has already been transformed into THCA, CBDA, or CBCA.
Research on hemp varieties shows that CBGA concentrations are highest earlier in the plant’s growth cycle. In one study of a CBG-producing hemp genotype, CBGA content in the flowers peaked at about 3.2% during an earlier growth stage and dropped to around 1.4% by the time the plant was fully mature. Leaves contained even less, ranging from roughly 0.1% to 1% depending on the growth stage and their position on the plant.
To get cannabis products rich in CBGA or its decarboxylated form CBG, breeders have developed specialized strains with reduced synthase activity. These plants are essentially “broken” at the conversion step, so CBGA accumulates instead of being turned into THCA or CBDA. Some growers also harvest these plants earlier than usual to capture more CBGA before conversion occurs.
CBGA vs. CBG: The Decarboxylation Step
CBGA and CBG are closely related but not identical. CBGA is the raw, acidic form found in living and freshly harvested cannabis. When exposed to heat, CBGA loses a carbon dioxide molecule and becomes CBG, the neutral (decarboxylated) form. This is the same process that turns THCA into THC when you smoke or vaporize flower.
If you’re eating raw cannabis or using a fresh extract, you’re consuming CBGA. If you smoke, vape, or bake with it, the heat converts CBGA into CBG. For intentional decarboxylation, heating at around 110°C (230°F) for about 60 minutes is a commonly referenced guideline for converting CBGA to CBG.
Potential Effects of CBGA on the Body
CBGA does not produce a high. Unlike THC, it has very low affinity for the CB1 and CB2 receptors in the endocannabinoid system, which are the receptors responsible for cannabis’s psychoactive effects.
Instead, CBGA appears to interact with a different set of receptors called PPARs (peroxisome proliferator-activated receptors). These receptors help regulate metabolism, inflammation, and fat storage. Research has identified CBGA as a dual agonist of two PPAR subtypes, PPARα and PPARγ, meaning it activates both. These same receptors are targets for existing medications used to manage metabolic conditions like high triglycerides and insulin resistance, which has generated scientific interest in CBGA’s potential therapeutic applications.
That said, most research on CBGA’s effects is still at the laboratory stage. It hasn’t been studied in large human clinical trials the way CBD has, so its practical health benefits remain uncertain. The existing data is promising enough to fuel ongoing research, but it’s far from settled science.
How CBGA Shows Up in Products
You’ll encounter CBGA in a few contexts. Full-spectrum CBD oils made with minimal heat processing may retain some CBGA alongside CBDA and other acidic cannabinoids. Raw cannabis juicing, which has a niche following, preserves CBGA because no heat is applied. And a growing number of products specifically marketed as CBG oils or CBG flower come from those specialty strains bred to accumulate CBGA rather than converting it.
On lab test results for cannabis flower or extracts, CBGA typically appears as its own line item. If you see a high CBGA percentage alongside low THC and CBD numbers, you’re looking at a CBG-type cultivar. If CBGA is listed at a fraction of a percent while THCA or CBDA dominates, that’s a standard cannabis or hemp variety where conversion has already done its work.